Your browser doesn't support javascript.
loading
Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
McLaren, Paul J; Porreca, Immacolata; Iaconis, Gennaro; Mok, Hoi Ping; Mukhopadhyay, Subhankar; Karakoc, Emre; Cristinelli, Sara; Pomilla, Cristina; Bartha, István; Thorball, Christian W; Tough, Riley H; Angelino, Paolo; Kiar, Cher S; Carstensen, Tommy; Fatumo, Segun; Porter, Tarryn; Jarvis, Isobel; Skarnes, William C; Bassett, Andrew; DeGorter, Marianne K; Sathya Moorthy, Mohana Prasad; Tuff, Jeffrey F; Kim, Eun-Young; Walter, Miriam; Simons, Lacy M; Bashirova, Arman; Buchbinder, Susan; Carrington, Mary; Cossarizza, Andrea; De Luca, Andrea; Goedert, James J; Goldstein, David B; Haas, David W; Herbeck, Joshua T; Johnson, Eric O; Kaleebu, Pontiano; Kilembe, William; Kirk, Gregory D; Kootstra, Neeltje A; Kral, Alex H; Lambotte, Olivier; Luo, Ma; Mallal, Simon; Martinez-Picado, Javier; Meyer, Laurence; Miro, José M; Moodley, Pravi; Motala, Ayesha A; Mullins, James I; Nam, Kireem.
Afiliación
  • McLaren PJ; Sexually Transmitted and Blood-Borne Infections Division at JC Wilt Infectious Diseases Research Centre, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada. paul.mclaren@phac-aspc.gc.ca.
  • Porreca I; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada. paul.mclaren@phac-aspc.gc.ca.
  • Iaconis G; Wellcome Trust Sanger Institute, Hinxton, UK.
  • Mok HP; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Mukhopadhyay S; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Karakoc E; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Cristinelli S; Wellcome Trust Sanger Institute, Hinxton, UK.
  • Pomilla C; Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Bartha I; Wellcome Trust Sanger Institute, Hinxton, UK.
  • Thorball CW; Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Tough RH; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Angelino P; Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Kiar CS; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Carstensen T; Precision Medicine Unit, Biomedical Data Science Center, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
  • Fatumo S; Sexually Transmitted and Blood-Borne Infections Division at JC Wilt Infectious Diseases Research Centre, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Porter T; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Jarvis I; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Skarnes WC; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Bassett A; Wellcome Trust Sanger Institute, Hinxton, UK.
  • DeGorter MK; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Sathya Moorthy MP; The African Computational Genomics (TACG) Research Group, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Tuff JF; Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
  • Kim EY; Wellcome Trust Sanger Institute, Hinxton, UK.
  • Walter M; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Simons LM; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Bashirova A; Wellcome Trust Sanger Institute, Hinxton, UK.
  • Buchbinder S; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Carrington M; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Cossarizza A; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
  • De Luca A; Sexually Transmitted and Blood-Borne Infections Division at JC Wilt Infectious Diseases Research Centre, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Goedert JJ; Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Goldstein DB; Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Haas DW; Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Herbeck JT; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA.
  • Johnson EO; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Kaleebu P; Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.
  • Kilembe W; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA.
  • Kirk GD; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Kootstra NA; Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA.
  • Kral AH; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
  • Lambotte O; University Division of Infectious Diseases, Siena University Hospital, Siena, Italy.
  • Luo M; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Mallal S; Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Martinez-Picado J; Institute for Genomic Medicine, Columbia University, New York, NY, USA.
  • Meyer L; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Miro JM; Department of Global Health, University of Washington, Seattle, WA, USA.
  • Moodley P; GenOmics and Translational Research Center and Fellow Program, RTI International, Research Triangle Park, NC, USA.
  • Motala AA; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.
  • Mullins JI; London School of Hygiene and Tropical Medicine, London, UK.
  • Nam K; Center for Family Health Research-Zambia, Lusaka, Zambia.
Nature ; 620(7976): 1025-1030, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37532928
ABSTRACT
HIV-1 remains a global health crisis1, highlighting the need to identify new targets for therapies. Here, given the disproportionate HIV-1 burden and marked human genome diversity in Africa2, we assessed the genetic determinants of control of set-point viral load in 3,879 people of African ancestries living with HIV-1 participating in the international collaboration for the genomics of HIV3. We identify a previously undescribed association signal on chromosome 1 where the peak variant associates with an approximately 0.3 log10-transformed copies per ml lower set-point viral load per minor allele copy and is specific to populations of African descent. The top associated variant is intergenic and lies between a long intergenic non-coding RNA (LINC00624) and the coding gene CHD1L, which encodes a helicase that is involved in DNA repair4. Infection assays in iPS cell-derived macrophages and other immortalized cell lines showed increased HIV-1 replication in CHD1L-knockdown and CHD1L-knockout cells. We provide evidence from population genetic studies that Africa-specific genetic variation near CHD1L associates with HIV replication in vivo. Although experimental studies suggest that CHD1L is able to limit HIV infection in some cell types in vitro, further investigation is required to understand the mechanisms underlying our observations, including any potential indirect effects of CHD1L on HIV spread in vivo that our cell-based assays cannot recapitulate.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Variación Genética / Infecciones por VIH / VIH-1 / ADN Helicasas / Carga Viral / Proteínas de Unión al ADN Tipo de estudio: Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Nature Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Variación Genética / Infecciones por VIH / VIH-1 / ADN Helicasas / Carga Viral / Proteínas de Unión al ADN Tipo de estudio: Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Nature Año: 2023 Tipo del documento: Article País de afiliación: Canadá